Drug Profile
Bovine haemoglobin-ATP-adenosine-GSH conjugate - HemoBioTech
Alternative Names: HemoTechLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Haemoglobins
- Mechanism of Action Oxygen carriers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypovolaemia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Hypovolaemia in Africa (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hypovolaemia in USA (Parenteral)
- 14 Jul 2005 Preclinical trials in Hypovolaemia in USA (unspecified route)